Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures
Recruiting
Phase 2
Interventional Study
Epilepsies, Partial
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 100 (estimated)
- Sponsor
- Ono Pharmaceutical Co., Ltd. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To evaluate the long-term safety and tolerability of cenobamate in Japanese epilepsy patients with partial seizures
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Subjects completed Study YKP3089C035 by SK Life Science.
Exclusion Criteria:
* Subjects that have previously discontinued for any reason from the Core study (YKP3089C035).
* Any significant changes to the medical history of the subject that in the opinion of the investigator…
Contacts
North America Clinical Trial Support Desk
+18665877745(Toll-Free)
CONTACT
International Clinical Trial Support Desk
+17162141777(Standard)
CONTACT